M.D. Anderson Cancer Center: Lymphoma trials
The registry lists 172 Lymphoma studies with M.D. Anderson Cancer Center as lead sponsor. 9 are open to participants now and 84 have results posted.
Early Phase 1 5Phase 1 52Phase 2 108Phase 3 7Phase 4 2No phase 21(a study in two phases counts in both)
Studies
Page 2 of 2. Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Venetoclax and Eprenetapopt for the Treatment of Relapsed of Refractory Mantle Cell LymphomaWithdrawnNCT04990778Phase 2
- Interrogating Biological Signaling Pathway Dysregulations and In Vitro Screening With Personalized Therapies in Relapsed or Refractory Mantle Cell Lymphoma, MCL MATCH TrialCompletedNCT04872413Not applicable
- Ipilimumab, Ibrutinib, and Nivolumab for the Treatment of Chronic Lymphocytic Leukemia and Richter TransformationWithdrawnNCT04781855Phase 1
- Mind-Body Medicine for the Improvement of Quality of Life in Adolescents and Young Adults Coping With LymphomaActive, not recruitingNCT04270266Not applicable
- Vorinostat and Combination Chemotherapy Before Donor Stem Cell Transplantation for the Treatment of Relapsed Aggressive B-cell or T-cell Non-Hodgkin LymphomaWithdrawnNCT04220008Phase 2
- Frequency of Cachexia in Ambulatory Cancer Patients and Psychological Burden in Patients and Their Primary CaregiversActive, not recruitingNCT04090619
- Modified Immune Cells (CD19-CD22 CAR T Cells) in Treating Patients With Recurrent or Refractory CD19 Positive, CD22 Positive Leukemia or LymphomaWithdrawnNCT04029038Phase 1/2
- Trabectedin and Venetoclax in Treating Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Resistant or Intolerant to a BTK InhibitorWithdrawnNCT03884972Phase 1
- Nivolumab and Ibrutinib in Treating Patients With Relapsed or Refractory Central Nervous System LymphomaCompletedNCT03770416Phase 2
- Cognitive Behavioral Therapy in Helping Patients With Acute Myeloid Leukemia or Lymphoma With Cancer-Related FatigueActive, not recruitingNCT03747757Phase 2
- CAR.CD19-CD28-zeta-2A-iCasp9-IL15-Transduced Cord Blood NK Cells, High-Dose Chemotherapy, and Stem Cell Transplant in Treating Participants With B-cell LymphomaWithdrawnNCT03579927Phase 1/2
- CD19-Specific T Cells Post AlloSCTTerminatedNCT03579888Phase 1
- IACS-010759 in Advanced CancersCompletedNCT03291938Phase 1
- Ibrutinib Plus Rituximab and Lenalidomide in Treating Elderly Participants With Newly Diagnosed Mantle Cell LymphomaWithdrawnNCT03232307Phase 2
- Patient-Derived Xenografts in Personalizing Treatment for Patients With Relapsed/Refractory Mantle Cell LymphomaCompletedNCT03219047Early Phase 1
- Study of Brentuximab Vedotin Plus TAK228 for Relapsed/Refractory Classical Hodgkin Lymphoma, Anaplastic Large Cell Lymphoma and Other CD30+Peripheral T-Cell LymphomasWithdrawnNCT03205891Phase 1
- Decision Aid Website in Helping to Make Decisions About Fertility in Participants With CancerActive, not recruitingNCT03141437Not applicable
- Panobinostat Combined With High-Dose Gemcitabine/Busulfan/Melphalan With Autologous Stem Cell Transplant for Patients With Refractory/Relapsed LymphomaWithdrawnNCT02961816Phase 2
- Engineered Donor Stem Cell Transplant in Treating Patients With Hematologic MalignanciesCompletedNCT02960646Phase 1
- Belinostat Combined With Azacitidine/Gemcitabine/Busulfan/Melphalan With Autologous Stem-Cell Transplantation in Refractory or Relapsed LymphomaWithdrawnNCT02701673Phase 1/2
- A Phase Ib Study of Belinostat With RDHAP Chemotherapy (Dexamethasone, Cytarabine, Cisplatinum) in Adults With Relapsed or Refractory Diffuse Large B-cell LymphomaWithdrawnNCT02532192Phase 1
- CD19-Specific T-cells in Treating Patients With Advanced Lymphoid MalignanciesCompletedNCT02529813Phase 1
- Tumor-Specific Clonotype, Metabolic Profile, and PET/CT in Predicting Chemotherapy Response in Patients With Relapsed or Refractory Diffuse Large B-cell LymphomaCompletedNCT02405078Early Phase 1
- Study of Loratadine for Pegfilgrastim Induced Bone Pain in Patients With Aggressive LymphomaTerminatedNCT02392039Early Phase 1
- Infusion of Allogeneic, 3rd Party CD19-specific T CellsWithdrawnNCT02274506Phase 1
- Trial of PCI-32765 (BTK Inhibitor) in Combination With Carfilzomib in Relapse/Refractory Mantle Cell LymphomaTerminatedNCT02269085Phase 1
- Concurrent Chemotherapy and Radiation Therapy for Newly Diagnosed Nasal NK Cell LymphomaActive, not recruitingNCT02106988Phase 2
- Rituximab + GM-CSF in Patients With Follicular B-Cell LymphomaCompletedNCT01939730Phase 2
- Carfilzomib Consolidation Therapy After Autologous Stem Cell Transplantation (ASCT) for Mantle Cell Lymphoma (MCL), T-cell Lymphoma (TCL), and Diffuse Large B-Cell Lymphoma (DLBCL)CompletedNCT01926665Phase 1
- CD5789 in Early Cutaneous T-Cell Lymphoma (CTCL)CompletedNCT01804335Phase 1
- Phase I/II Carfilzomib Plus Lenalidomide and Rituximab in the Treatment of Relapsed/Refractory Mantle Cell LymphomaTerminatedNCT01729104Phase 1
- Bendamustine in Acute Lymphoblastic Leukemia/Lymphoma (ALL)WithdrawnNCT01649622Phase 2
- NK Cells in Cord Blood TransplantationStatus unknownNCT01619761Phase 1
- Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant SurvivorsActive, not recruitingNCT01608152
- Romidepsin, Ifosfamide, Carboplatin, and Etoposide in Treating Participants With Relapsed or Refractory Peripheral T-Cell LymphomaCompletedNCT01590732Phase 1
- Infusion of Allogeneic CD19-Specific T Cells From Peripheral BloodCompletedNCT01497184Phase 1
- Cord Blood Fucosylation to Enhance Homing and Engraftment in Patients With Hematologic MalignanciesCompletedNCT01471067Phase 1
- Combination of Lenalidomide and Rituximab in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL-SLL)Active, not recruitingNCT01446133Phase 2
- Vorinostat With Gemcitabine, Busulfan, and Melphalan With Stem Cell Transplant (SCT) in Relapsed or Refractory Lymphoid MalignanciesCompletedNCT01421173Phase 1
- Infusion of Allogeneic Umbilical Cord Blood-Derived Cluster of Differentiation Antigen 19 (CD19)-Specific T CellsCompletedNCT01362452Phase 1
- SGN-35 in CD30-positive Lymphoproliferative Disorders (ALCL), Mycosis Fungoides (MF), and Extensive Lymphomatoid Papulosis (LyP)Active, not recruitingNCT01352520Phase 2
- Rituximab Maintenance After Autologous TransplantationTerminatedNCT01103388Phase 3
- Antimicrobial Solution or Saline Solution in Maintaining Catheter Patency and Preventing Catheter-Related Blood Infections in Patients With MalignanciesWithdrawnNCT01101412Phase 1/2
- Trial of Curcumin in Cutaneous T-cell Lymphoma PatientsWithdrawnNCT00969085Phase 2
- CD19-specific T Cell Infusion in Patients With B-Lineage Lymphoid MalignanciesCompletedNCT00968760Phase 1
- Fludarabine, Bendamustine, and Rituximab in Treating Participants With Lymphoid Cancers Undergoing Stem Cell TransplantCompletedNCT00880815Phase 1
- Treatment of Macroglobulinemic Lymphoma With 2CdA, Cyclophosphamide and RituximabCompletedNCT00667329Phase 1
- Combined CT Colonography and PET Imaging in Mantle Cell LymphomaWithdrawnNCT00541424
- Evaluation of a Novel CT-On-Rails or Trilogy Stereotactic Spine Radiotherapy System (SSRS)Active, not recruitingNCT00508443Phase 1/2
- Molecular Epidemiology of Lymphoma PatientsWithdrawnNCT00488553
- Anti-Third Party T Lymphocytes With Nonmyeloablative Stem Cell Transplantation for Indolent Lymphoid MalignanciesTerminatedNCT00473551Phase 1
- Velcade Plus ICE for Patients With Relapsed Classical Hodgkin LymphomaCompletedNCT00439361Phase 1
- Gemcitabine Plus Busulfan, Melphalan and Hematopoietic Cell Transplant for Advanced Lymphoid MalignanciesCompletedNCT00410982Phase 1
- Immunotherapy With NK Cell, Rituximab and Rhu-GMCSF in Non-Myeloablative Allogeneic Stem Cell TransplantationCompletedNCT00383994Phase 1
- Pharmacokinetic Evaluation of Rasburicase in Patients With Leukemia and/or Lymphoma at High Risk of TLSCompletedNCT00360438Phase 1/2
- Influenza Vaccination in Patients Receiving Antineoplastic Therapy for Non-Hodgkin's LymphomaCompletedNCT00307710Phase 2
- Photopheresis as an Interventional Therapy for the Treatment of CTCL (Cutaneous T-Cell Lymphoma, Mycosis Fungoides) Stage 1A, 1B, 2ACompletedNCT00221039Phase 4
- Campath-1H and Allogeneic Blood Stem Cell Transplantation for Lymphoid MalignanciesTerminatedNCT00038883Not applicable
- Blood Transplantation for Patients With Hematologic Malignancies or Bone Marrow Failure StatesTerminatedNCT00038779Not applicable
- Study Of Yttrium-ibritumomab (Zevalin) For the Treatment Of Patients With Relapsed And Refractory Mantle Cell LymphomaCompletedNCT00038623Phase 2
- Proteasome Inhibitor PS-341 Relapsed or Refractory B Cell Lymphomas Previously Treated With ChemotherapyCompletedNCT00038571Phase 2
- A Phase II Study of Paclitaxel and Topotecan With Filgrastim-SD/01 Support For Relapsed and Refractory Aggressive Non-Hodgkin's LymphomaCompletedNCT00038545Phase 2
- A Study Of Deoxycoformycin(DCF)/Pentostatin In Lymphoid MalignanciesCompletedNCT00038025Phase 2
- Liposomal Tretinoin in Treating Patients With Recurrent or Refractory Hodgkin's DiseaseWithdrawnNCT00005969Phase 2
- Chemotherapy, Radiation Therapy, and Peripheral Stem Cell Transplantation in Treating Patients With Hematologic CancerCompletedNCT00005092Phase 1
- Combination Chemotherapy in Treating Patients With Newly Diagnosed Mantle Cell LymphomaCompletedNCT00003311Phase 2
- Irinotecan in Treating Patients With Recurrent or Refractory Non-Hodgkin's LymphomaCompletedNCT00003245Phase 2
- Combination Chemotherapy in Treating Patients With LymphomaCompletedNCT00002835Phase 3
- Bone Marrow Transplantation in Treating Patients With LymphomaCompletedNCT00002829Phase 2
- Antibiotic Therapy and Antacids in Patients With Malt Lymphoma of the StomachCompletedNCT00002682Phase 2
- Combination Chemotherapy in Treating Patients With Intermediate-Grade or Immunoblastic Non-Hodgkin's LymphomaCompletedNCT00002565Phase 3
- Combination Chemotherapy in Treating Patients With AIDS-Related LymphomaCompletedNCT00002524Phase 2